AbCellera Biologics Inc.
ABCL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001703057
In the last 90 days, AbCellera Biologics Inc. insiders filed 4 open-market purchases and 0 sales; 150 institutions reported holding it in 13F filings for Q2 2026, worth $908.8M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in AbCellera Biologics Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 170
- −10 vs. Q1 2023
- Shares held
- 124.8M
- −5.08M (−3.9%) vs. Q1 2023
- Total value
- $809.1M
- −$170.4M (−17.4%) vs. Q1 2023
- New holders
- 38
- 42 more added
- Sold out
- 48
- 50 more reduced
3 institutions that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ABCL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 150 | $908.8M |
| Q1 2026 | 138 | $434.0M |
| Q4 2025 | 144 | $370.6M |
| Q3 2025 | 141 | $524.6M |
| Q2 2025 | 128 | $370.6M |
| Q1 2025 | 129 | $280.1M |
| Q4 2024 | 146 | $333.9M |
| Q3 2024 | 139 | $274.6M |
| Q2 2024 | 148 | $338.3M |
| Q1 2024 | 154 | $547.4M |
| Q4 2023 | 143 | $681.1M |
| Q3 2023 | 138 | $551.8M |
| Q2 2023 | 170 | $809.1M |
| Q1 2023 | 183 | $980.7M |
| Q4 2022 | 203 | $1.30B |
| Q3 2022 | 190 | $1.21B |
| Q2 2022 | 162 | $1.26B |
| Q1 2022 | 130 | $1.10B |
| Q4 2021 | 124 | $1.63B |
| Q3 2021 | 116 | $1.98B |
| Q2 2021 | 114 | $1.99B |
| Q1 2021 | 86 | $2.42B |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding AbCellera Biologics Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −16,571−100.0% | Sold out |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −15,400−100.0% | Sold out |
| Westwood Holdings Group Inc. | 0 | $0 | 0.00% | −15,408−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −13,230−100.0% | Sold out |
| Mackenzie Financial Corp | 0 | $0 | 0.00% | −12,712−100.0% | Sold out |
| Xponance, Inc. | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −11,589−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −11,212−100.0% | Sold out |
| Janney Montgomery Scott LLC | 0 | $0 | 0.00% | −10,193−100.0% | Sold out |
| Atria Wealth Solutions, Inc. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Renaissance Capital LLC | 0 | $0 | 0.00% | −7,957−100.0% | Sold out |
| Banque Cantonale Vaudoise | 0 | $0 | 0.00% | −6,284−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −6,070−100.0% | Sold out |
| Belpointe Asset Management LLC | 0 | $0 | 0.00% | −5,300−100.0% | Sold out |
| Gladius Capital Management LP | 0 | $0 | 0.00% | −3,361−100.0% | Sold out |
| Slow Capital, Inc. | 0 | $0 | 0.00% | −1,638−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −1,168−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −583−100.0% | Sold out |
| ETF Managers Group, LLC | – | – | – | – | Not filed |
| Asset Management Corp | – | – | – | – | Not filed |
| Kula Investments, LLC | – | – | – | – | Not filed |